AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 7 - (NewsRx.com & NewsRx.net) -- CpG immuno-stimulatory motifs enhanced the humoral, but not the cellular, immune responses against hepatitis C virus core protein after DNA-based immunization.
According to published research from the United States, "Chronic HCV infection is associated with a high morbidity and mortality rate, and currently a prophylactic or therapeutic vaccine is not available. DNA-based immunization is a powerful method to generate cellular and humoral immune responses. However, DNA immunization against HCV core results only in a weak humoral immune response demonstrated in several studies."
"Therefore, co-immunization with a novel adjuvant may enhance such potentially important immune responses," said Jens Encke and colleagues at Harvard Medical School. "We examined whether unmethylated CpG motifs in the form of oligodeoxynucleotides (ODN) or E. coli DNA can act as adjuvants for a DNA vaccination approach, since CpG motifs have been shown to stimulate the innate immune system as well as B and T cell immune reactivity. The present study demonstrates that CpG motifs enhance in vivo antibody levels after DNA immunization against HCV core. However, despite some in vitro activity of CpG ...
Source: HighBeam Research, CpG enhances antibody response against hepatitis C virus core protein.